MABVAX THERAPEUTICS HOLDINGS, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8217b63b-a5cf-4d6e-b9e2-16bd1b142849/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001654954-18-003518 |
| FY 2016 | $148.1k | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-001584 |
| FY 2015 | $1.3M | 2015-01-01 – 2015-12-31 | evidence 0001415889-16-005062 |
| FY 2014 | $314.2k | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-117877 |
| FY 2013 | $366.4k | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-346213 |
| FY 2012 | $1.4M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-346213 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MABVAX THERAPEUTICS HOLDINGS, INC. — all facts · Net Income · Operating Income